
TrovaGene Inc (NASDAQ:TROV) Strengthens Board With Appointment Of Dr. Athena Countouriotis
TrovaGene Inc (NASDAQ:TROV) reported the strengthening and expansion of its Board with the election of Athena Countouriotis, M.D., who brings extensive experience leading clinical advancement













